Top-down Infliximab Study in Kids With Crohn's Disease

Trial Profile

Top-down Infliximab Study in Kids With Crohn's Disease

Phase of Trial: Phase IV

Latest Information Update: 02 Aug 2018

At a glance

  • Drugs Infliximab (Primary) ; Azathioprine; Prednisolone
  • Indications Crohn's disease
  • Focus Therapeutic Use
  • Acronyms TISKids
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 08 Feb 2017 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2019.
    • 09 Aug 2015 New registry source identified and integrated (NCT02517684 ).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top